Literature DB >> 23535738

The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.

Tai-Pang Ip, Shing-Kee William Cheung, Tak-Cheong Cheung, Tak-Cheong Choi, Siu-Lun Eddie Chow, Yiu-Yan Andrew Ho, Sik-Yau Anita Kan, Wai-Chee Annie Kung, Ka-Kui Lee, Ka-Li Frankie Leung, Yin-Yan Jenny Leung, Seen-Tsing Sue Lo, Chung-Tai Sy, Yat-Wa Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23535738

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN： 1024-2708            Impact factor:   2.227


× No keyword cloud information.
  18 in total

1.  Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.

Authors:  A C Looker; N Sarafrazi Isfahani; B Fan; J A Shepherd
Journal:  Osteoporos Int       Date:  2017-03-18       Impact factor: 4.507

2.  Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.

Authors:  J C Lo; S Kim; M Chandra; B Ettinger
Journal:  Osteoporos Int       Date:  2016-07-28       Impact factor: 4.507

3.  Prevalence, Safety and Long-Term Retention Rates of Biologics in Hong Kong from 2001 to 2015.

Authors:  Mengqin Ge; Kenneth K Man; Celine S Chui; Esther W Chan; Ian C Wong; Xue Li
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

Review 4.  A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.

Authors:  J F Chen; K H Yang; Z L Zhang; H C Chang; Y Chen; H Sowa; S Gürbüz
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

Review 5.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

6.  Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.

Authors:  E Cheung; C-L Cheung; A W C Kung; K C B Tan
Journal:  Osteoporos Int       Date:  2013-11-06       Impact factor: 4.507

7.  The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.

Authors:  M Chakhtoura; W D Leslie; M McClung; A M Cheung; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2016-09-20       Impact factor: 4.507

Review 8.  Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.

Authors:  P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams
Journal:  Osteoporos Int       Date:  2019-12-01       Impact factor: 4.507

Review 9.  Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines.

Authors:  Joanna E M Sale; Matthew Gray; Daniel Mancuso; Taucha Inrig; Gilles Boire; Marie-Claude Beaulieu; Larry Funnell; Earl Bogoch
Journal:  Rheumatol Int       Date:  2018-10-26       Impact factor: 2.631

10.  Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.

Authors:  M Chandran; P J Mitchell; T Amphansap; S K Bhadada; M Chadha; D-C Chan; Y-S Chung; P Ebeling; N Gilchrist; A Habib Khan; P Halbout; F L Hew; H-P T Lan; T C Lau; J K Lee; S Lekamwasam; G Lyubomirsky; L B Mercado-Asis; A Mithal; T V Nguyen; D Pandey; I R Reid; A Suzuki; T T Chit; K L Tiu; T Valleenukul; C K Yung; Y L Zhao
Journal:  Osteoporos Int       Date:  2021-01-27       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.